Skip to main content

EDITORIAL article

Front. Genet., 26 January 2023
Sec. Genetics of Common and Rare Diseases
This article is part of the Research Topic Impact of Hyperglycemia induced oxidative stress in Genetics and Epigenetics of Metabolic Diseases View all 6 articles

Editorial: Impact of hyperglycemia induced oxidative stress in genetics and epigenetics of metabolic diseases

  • 1Department of Medical Laboratory Sciences, College of Applied Medical Science, University of Hail, Hail, Saudi Arabia
  • 2Department of Biomedical Engineering, Stony Brook University, New York, NY, United States
  • 3Department of Medical Biotechnology, Yeungnam University, Gyeongsan, Republic of Korea
  • 4Department of Basic Medical and Dental Sciences, College of Dentistry, University of Hail, Hail, Saudi Arabia

This Research Topic brings together various contributions that highlight cutting-edge methods and analyses for dealing with oxidative stress brought on by hyperglycemia in data on the genetics and epigenetics of metabolic diseases that have been collected using a variety of modalities, both real and simulated. With an emphasis on the connection between hyperglycemia, oxidative stress, genetics, and epigenetics, these methods help us understand the mechanisms behind metabolic disorders. The oxidative stress and hyperglycemia result in the non-enzymatic glycation reaction, which is one of the primary causes of metabolic disorders like diabetes, cancer, etc. (Akhter et al., 2014; Akhter et al., 2017; Ahmad et al., 2018a; Shahab et al., 2018).

There are numerous studies that hold the role of hyperglycemia and glycation reaction in cancer state disease (Ashraf et al., 2016; Ahmad et al., 2018b; Ahmad et al., 2018c; Jabir et al., 2018; Khan et al., 2018). Our research team has recently demonstrated the significance of the non-enzymatic glycation process in the epigenetics of cancer (Rehman et al., 2022).

The first article on this subject (Goel et al.), introduces metformin and multiple mechanisms (excluding AMPK activation) through which Metformin may have positive effects in these environments and includes Embase and PubMed/MEDLINE searched evidence that metformin has diversified effects on the systems of the human body. It has been demonstrated to have antioxidant, anti-inflammatory, metabolic, cardioprotective, neuroprotective, antibacterial, and anti-cancer actions. Recently, it has also been discovered to have efficacy in contrast to SARS-CoV-2. The AMPK pathway was identified as one among them all for its effectiveness and efficiency. The authors demonstrate its grand potential, demonstrating that it is capable of being included in treatment plans for conditions other than type 2 diabetes mellitus (T2DM).

Using a different strategy, Bai et al. investigate the relationship between autophagy-related biomarkers in Diabetic Nephropathy by examining the differentially expressed genes associated with autophagy (DEARGs) between Diabetic Nephropathy and samples of healthy renal tubules. They identified a new biomarker of autophagy linked to tubulointerstitial damage in DN (Bai et al.). The author uses bioinformatics analysis to verify the 10 DN patients’ renal tubules’ gene expression profiles, 24 healthy controls, and 43 DEARGs. Protein-protein interactions were used to screen for the hub gene prolyl 4-hydroxylase subunit beta (P4HB), which was then confirmed by using additional datasets and stimulating HK-2 cells under conditions of high glucose concentration. On DEARGs, association analysis, Gene Ontology (GO), and Kyoto Encyclopedia of Genes and Genomes (KEGG) searches were made. Their findings showed a correlation between renal function and P4HB expression in renal tubules. Additionally, a methodology of this research that forecasts data from the GEO database on the gene expression of human renal tubulointerstitial was also demonstrated (GSE30122). In summary, their research revealed P4HB as a new DN-related autophagy biomarker and offered fresh perspectives for understanding the molecular mechanisms underlying Diabetic Nephropathy.

Xi, Zhang, et al., 2022, proposed a unique strategy, where ribose and glucose were glycated in vitro to confirm their impact upon epigenetics such as histone methylation and demethylation Xi et al. Specifically, Xi et al. report that after treatment with D-ribose glycated BSA, in SH-SY5Y cells, demethylation of histone 3 (H3K4) was seen together with noticeably elevated amounts of plant homeodomain finger protein eight and lysine-specific demethylase-1 (LSD1) (PHF8). Furthermore, the scientists verified that the presence of D-ribose glycated protein caused considerable demethylation of H3K4me3, H3K4, and H3K4me2. Further evidence of histone demethylation was found in the cell-culture media of SH-SY5Y cells along with D-ribose glycated BSA, where formaldehyde levels had increased. This study offers a fresh understanding of the ribose metabolic disorders-related epigenetic mechanism of diabetic Mellitus (DM). One publication has been contributed to this Research Topic regarding the development of autoantibodies against reactive oxygen species (ROS) modified Histone H1 Protein and its connection to lymphoma.

The design of new technical tools for structural and functional analysis can also benefit from information-based measures. Wang et al. investigated the relationship between the information content of oxidative stress and varicocele. Clinical palpation reveals varicocele as the main factor impacting male fertility. Although the majority of juvenile varicocele cases are asymptomatic, as patients age and the varicocele’s course worsen, symptoms such as testicular atrophy, infertility, and scrotal pain and discomfort gradually develop. These symptoms have an enormous effect on a patient’s physical and mental health. In the setting of a drop in fertility, the author described damage from oxidative stress’s significance in the molecular biology and pathophysiology of varicocele.

In the Binsaleh et al. study (Binsaleh et al.), the histone H1 (His-h1) protein was altered by ROS. Evaluations of the chemical and structural changes were made. To comprehend ROS and alter histone H1, individuals with Hodgkin lymphoma and non-Hodgkin lymphoma were chosen. Then, using biochemical and immunological methods, serum autoantibodies, inflammatory cytokines, and indicators of oxidative stress were investigated. The Langmuir plot was also used to evaluate the development of immunological complexes between antigens and antibodies. The findings imply that the protein’s cryptic neo-epitopes, which autoantibodies were produced against, are exposed by the ROS alterations of histone H1. These alterations may have an impact on how histone DNA interacts, and they may also be associated with gene dysregulation. Their findings indicate that these minor molecular changes coupled with immunological dysregulation may worsen the disease. Developing a new technical instrument for structural and functional analysis can also benefit from information-based measures. We hope that this Research Topic will serve as a helpful resource for the reader regarding the most recent developments in the rapidly expanding field of tools based on information theory and utilized in the study of neuroscience.

Author contributions

SA and SK contributed to conception and design of the study. KA organized the database. FA performed the analysis, wrote the first draft of the manuscript. All authors contributed to manuscript revision, read, and approved the submitted version.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

References

Ahmad, S., Akhter, F., Shahab, U., Rafi, Z., Khan, M. S., Nabi, R., et al. (2018a). Do all roads lead to the rome? The glycation perspective. Seminars cancer Biol. 49, 9–19. doi:10.1016/j.semcancer.2017.10.012

PubMed Abstract | CrossRef Full Text | Google Scholar

Ahmad, S., Khan, H., Siddiqui, Z., Khan, M. Y., Rehman, S., Shahab, U., et al. (2018b). AGEs, RAGEs and s-RAGE; friend or foe for cancer. Seminars Cancer Biol. 49, 44–55. doi:10.1016/j.semcancer.2017.07.001

PubMed Abstract | CrossRef Full Text | Google Scholar

Ahmad, S., Khan, M. Y., Rafi, Z., Khan, H., Siddiqui, Z., Rehman, S., et al. (2018c). Oxidation, glycation and glycoxidation-The vicious cycle and lung cancer. Seminars cancer Biol. 49, 29–36. doi:10.1016/j.semcancer.2017.10.005

PubMed Abstract | CrossRef Full Text | Google Scholar

Akhter, F., Khan, M. S., and Ahmad, S. (2014). Acquired immunogenicity of calf thymus DNA and LDL modified by D-ribose: A comparative study. Int. J. Biol. Macromol. 72, 1222–1227. doi:10.1016/j.ijbiomac.2014.10.034

PubMed Abstract | CrossRef Full Text | Google Scholar

Akhter, F., Khan, M. S., Faisal, M., Alatar, A. A., and Ahmad, S. (2017). Detection of circulating auto-antibodies against ribosylated-LDL in diabetes patients. J. Clin. laboratory analysis 31 (2), e22039. doi:10.1002/jcla.22039

PubMed Abstract | CrossRef Full Text | Google Scholar

Ashraf, J. M., Shahab, U., Tabrez, S., Lee, E. J., Choi, I., Ahmad, S., et al. (2016). DNA glycation from 3-deoxyglucosone leads to the formation of AGEs: Potential role in cancer auto-antibodies. Cell Biochem. Biophysics 74 (1), 67–77. doi:10.1007/s12013-015-0713-6

PubMed Abstract | CrossRef Full Text | Google Scholar

Jabir, N. R., Ahmad, S., and Tabrez, S. (2018). An insight on the association of glycation with hepatocellular carcinoma. Seminars Cancer Biol. 49, 56–63. doi:10.1016/j.semcancer.2017.06.005

PubMed Abstract | CrossRef Full Text | Google Scholar

Khan, H., Khan, M. S., and Ahmad, S. (2018). The in vivo and in vitro approaches for establishing a link between advanced glycation end products and lung cancer. J. Cell. Biochem. 119 (11), 9099–9109. doi:10.1002/jcb.27170

PubMed Abstract | CrossRef Full Text | Google Scholar

Rehman, S., Aatif, M., Rafi, Z., Khan, M. Y., Shahab, U., Ahmad, S., et al. (2022). Effect of non-enzymatic glycosylation in the epigenetics of cancer. Seminars cancer Biol. 83, 543–555. doi:10.1016/j.semcancer.2020.11.019

CrossRef Full Text | Google Scholar

Shahab, U., Ahmad, M. K., Mahdi, A. A., Waseem, M., Arif, B., Ahmad, S., et al. (2018). The receptor for advanced glycation end products: A fuel to pancreatic cancer. Seminars cancer Biol. 49, 37–43. doi:10.1016/j.semcancer.2017.07.010

PubMed Abstract | CrossRef Full Text | Google Scholar

Keywords: hyperglycemia, metabolic disorders, oxidative stress, genetics, epigenetics

Citation: Ahmad S, Akhter F, Ahmad K and Khan S (2023) Editorial: Impact of hyperglycemia induced oxidative stress in genetics and epigenetics of metabolic diseases. Front. Genet. 14:1123665. doi: 10.3389/fgene.2023.1123665

Received: 14 December 2022; Accepted: 04 January 2023;
Published: 26 January 2023.

Edited and reviewed by:

Jordi Pérez-Tur, Spanish National Research Council (CSIC), Spain

Copyright © 2023 Ahmad, Akhter, Ahmad and Khan. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Saheem Ahmad, ahmadsaheem@gmail.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.